[Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
D000404:Ajmaline / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001464:Barium / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005029:Ethylenediamines / Q000494:pharmacology* / Q000633:toxicity; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D011433:Propranolol / Q000494:pharmacology* / Q000633:toxicity; D011802:Quinidine / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013328:Strophanthins / Q000494:pharmacology; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D005029:Ethylenediamines; D013328:Strophanthins; D000404:Ajmaline; D001464:Barium; D011433:Propranolol; D011802:Quinidine
Uber antiarrhythmische, kreislauf- und toxische Wirkungen von N.N'-Bis-[3(2'-äthoxyphenoxy)-2-hydroxypropyl]-äthylendiamin (Falirytmin) im Vergleich mit Propranolol, Chinidin und Ajmalin